Kamada (KMDA) Change in Inventory (2013 - 2026)
Kamada's (KMDA) quarterly Change in Inventory came in at -$494000.0 in Q1 2026, down 207.16% YoY from $461000.0 in Q1 2025, and down 205.33% on a QoQ basis from $469000.0 in Q4 2025.
Kamada (KMDA) Change in Inventory (2013 - 2026) Analysis & Trends
Kamada (KMDA) has 14 years of Change in Inventory data on file, last reported at -$494000.0 in Q1 2026.
- Quarterly Change in Inventory fell 207.16% year-over-year to -$494000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 218.2% YoY) and the FY2025 annual result came in at -$6.1 million, down 163.4% from the prior year.
- Change in Inventory fell to -$494000.0 in Q1 2026, from $469000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $7.2 million in Q3 2024 to a low of -$14.7 million in Q4 2023.
- A 5-year average of -$164425.5 and a median of $4245.0 in 2022 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 75796.32% in 2023, down 345989.28% in 2023.
- Tracing KMDA's Change in Inventory over 5 years: stood at $4245.0 in 2022, then sank by 345989.28% to -$14.7 million in 2023, then jumped by 50.55% to -$7.3 million in 2024, then soared by 106.46% to $469000.0 in 2025, then tumbled by 205.33% to -$494000.0 in 2026.
- The last three Change in Inventory figures came in at -$494000.0 (Q1 2026), $469000.0 (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kamada | 458.29 Mn | 428.82 Mn | 22.47 Mn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.44 Mn |
| Jun 30, 2026 | -1.44 Mn |
| Mar 31, 2026 | -494,000.00 |
| Mar 31, 2026 | -494,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Sep 30, 2025 | -3.33 Mn |
| Sep 30, 2025 | -3.33 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 461,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | -7.26 Mn |
| Dec 31, 2024 | -7.26 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Mar 31, 2024 | 4.13 Mn |